Home/Filings/4/0001104659-22-063450
4//SEC Filing

Raphael Erez 4

Accession 0001104659-22-063450

CIK 0001533998other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 5:02 PM ET

Size

6.0 KB

Accession

0001104659-22-063450

Insider Transaction Report

Form 4
Period: 2022-05-18
Raphael Erez
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2022-05-18+275,0001,113,259 total
Holdings
  • Common Stock

    (indirect: By Dicilyon Consulting and Investment Ltd.)
    37,876
Footnotes (2)
  • [F1]The shares vest over three years as follows: 8.333% shall vest after 3 months from the grant date, and the remaining shares vest in 11 equal instalments every 3 months thereafter.
  • [F2]The amount shown represents the beneficial ownership of the issuer's securities held by Dicilyon Consulting and Investment Ltd. which may be deemed to be attributable to Mr. Raphael because Mr. Raphael possesses voting and dispositive power over the securities held by Dicilyon Consulting and Investment Ltd. by virtue of a proxy. Mr. Raphael disclaims beneficial ownership of the securities set forth herein.

Issuer

DarioHealth Corp.

CIK 0001533998

Entity typeother

Related Parties

1
  • filerCIK 0001668046

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 5:02 PM ET
Size
6.0 KB